AI-Driven Optimization of Nanoparticle-Based Gene Delivery Systems

Artificial Intelligence (AI)

The convergence of artificial intelligence (AI) with nanomedicine, particularly in the design and optimization of gene delivery systems, offers transformative possibilities in precision medicine. Nanoparticle-based delivery vectors are increasingly favored for their versatility, lower immunogenicity, and customizable properties. However, their development is complex, requiring careful consideration of numerous physicochemical factors. Traditional trial-and-error methods are insufficient to navigate this complexity, necessitating advanced AI techniques for optimization. Machine learning (ML) and deep learning (DL) algorithms, trained on experimental data, provide predictive insights into how variations in nanoparticle properties influence gene delivery efficiency and cytotoxicity. These models can be iteratively improved as new data becomes available, creating a continuous cycle of optimization. AI also facilitates real-time monitoring and adjustment of gene delivery systems, enhancing their efficacy and safety. Moreover, deep learning techniques, such as convolutional neural networks (CNNs) and generative models, further refine nanoparticle formulations by processing image-based data and generating novel designs. Reinforcement learning enables the simulation of biological environments, iterating on nanoparticle performance under varying conditions. AI also supports the integration of multimodal datasets, improving predictive accuracy and biological interpretability. Despite challenges related to data quality, standardization, and model interpretability, AI-driven approaches are poised to revolutionize gene delivery systems, paving the way for safer, more efficient, and personalized therapeutic strategies in nanomedicine.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.